
991 Serial monitoring of serum HER-2 extracellular domain (H-ECD) during herceptin-taxol chemotherapy (CT) for metastatic breast cancer (MBC) pts: preliminary results from the French experience (HER.ME.S protocol)
J.P. Lotz, D. Brault, K. Le Lay, M. Campione, P. Kerbrat, H. Hocini, F. Maindrault-Goebel, C. Tsé, S. Provent, R. LaunoisVolume:
1
Année:
2003
Langue:
english
DOI:
10.1016/s1359-6349(03)91018-4
Fichier:
PDF, 170 KB
english, 2003